These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11268317)

  • 1. Non-myeloablative allogeneic stem cell transplantation in children.
    Miniero R; Zecchina G; Nagler A
    Haematologica; 2000 Nov; 85(11 Suppl):12-7. PubMed ID: 11268317
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphocyte reconstitution following non-myeloablative hematopoietic stem cell transplantation follows two patterns depending on age and donor/recipient chimerism.
    Savage WJ; Bleesing JJ; Douek D; Brown MR; Linton GM; Malech HL; Horwitz ME
    Bone Marrow Transplant; 2001 Sep; 28(5):463-71. PubMed ID: 11593319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for childhood central nervous system tumors.
    Marachelian A; Butturini A; Finlay J
    Bone Marrow Transplant; 2008 Jan; 41(2):167-72. PubMed ID: 18176620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen.
    Morecki S; Gelfand Y; Nagler A; Or R; Naparstek E; Varadi G; Engelhard D; Akerstein A; Slavin S
    Bone Marrow Transplant; 2001 Aug; 28(3):243-9. PubMed ID: 11535991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower incidence of Bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning.
    Yoshihara S; Tateishi U; Ando T; Kunitoh H; Suyama H; Onishi Y; Tanosaki R; Mineishi S
    Bone Marrow Transplant; 2005 Jun; 35(12):1195-200. PubMed ID: 15852024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic stem cell transplantation in childhood inherited bone marrow failure syndrome.
    Gluckman E; Wagner JE
    Bone Marrow Transplant; 2008 Jan; 41(2):127-32. PubMed ID: 18084332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloablative conditioning for hematopoietic stem-cell transplantation in patients with non-malignant diseases.
    Ringdén O; Svenberg P; Le Blanc K; Mattsson J; Remberger M
    Bone Marrow Transplant; 2006 Aug; 38(4):321-2. PubMed ID: 16819434
    [No Abstract]   [Full Text] [Related]  

  • 8. Once-daily intravenous busulfan with therapeutic drug monitoring compared to conventional oral busulfan improves survival and engraftment in children undergoing allogeneic stem cell transplantation.
    Bartelink IH; Bredius RG; Ververs TT; Raphael MF; van Kesteren C; Bierings M; Rademaker CM; den Hartigh J; Uiterwaal CS; Zwaveling J; Boelens JJ
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):88-98. PubMed ID: 18158965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of experimental murine models to assess novel agents of hematopoietic stem and progenitor cell mobilization.
    Herbert KE; Lévesque JP; Haylock DN; Prince HM
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):603-21. PubMed ID: 18489986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-bacterial infections in allogeneic non-myeloablative stem cell transplant recipients.
    Narreddy S; Mellon-Reppen S; Abidi MH; Klein JL; Peres E; Heilbrun LK; Smith D; Alangaden G; Chandrasekar PH
    Transpl Infect Dis; 2007 Mar; 9(1):3-10. PubMed ID: 17313464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting hematopoietic progenitor cell mobilization: an analysis of 307 patients.
    Mendrone A; Arrais CA; Saboya R; Chamone Dde A; Dulley FL
    Transfus Apher Sci; 2008 Dec; 39(3):187-92. PubMed ID: 19036640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fludarabine based reduced intensity conditioning regimens in children undergoing allogeneic stem cell transplantation for severe aplastic anemia.
    George B; Mathews V; Viswabandya A; Kavitha ML; Srivastava A; Chandy M
    Pediatr Transplant; 2008 Feb; 12(1):14-9. PubMed ID: 18086256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-myeloablative conditioning for hemopoietic stem cell transplantation--does it work?
    Cheong SK; Eow GI; Leong CF
    Malays J Pathol; 2002 Jun; 24(1):1-8. PubMed ID: 16329549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early renal injury after myeloablative allogeneic and autologous hematopoietic cell transplantation.
    Caliskan Y; Besisik SK; Sargin D; Ecder T
    Bone Marrow Transplant; 2006 Jul; 38(2):141-7. PubMed ID: 16770317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases.
    Resnick IB; Shapira MY; Slavin S
    Transpl Immunol; 2005 Aug; 14(3-4):207-19. PubMed ID: 15982565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease.
    Lee S; Cho BS; Kim SY; Choi SM; Lee DG; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1083-94. PubMed ID: 17697971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
    Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.
    Majhail NS; Mothukuri JM; Brunstein CG; Weisdorf DJ
    Biol Blood Marrow Transplant; 2009 May; 15(5):564-73. PubMed ID: 19361748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advantages and limitations of (non-)myeloablative allogeneic stem cell transplantation.
    Huugen D; Schouten HC; Bos GM
    Neth J Med; 2002 May; 60(4):162-9. PubMed ID: 12164394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.